VC-backed Neurana Pharmaceuticals recruits Thompson as president and CEO
Neurana Pharmaceuticals Inc, a specialty pharmaceutical company focused on treating neuromuscular conditions, has appointed Craig Thompson as president and CEO. Previously, Thompson worked at Anthera Pharmaceuticals where he was president and CEO. Neurana's backers include Sofinnova Ventures, New Leaf Venture Partners, H.I.G. BioHealth Partners, Longitude Capital and MagnaSci Ventures.
17 July 2018•3 mins read
